Independent Associations of Serum 25-hydroxyvitamin D3 and D2 with Depressive Symptoms in Females

被引:6
|
作者
Li, Ping [1 ]
Zhao, Yanru [1 ]
Fan, Xinna [1 ]
Wang, Jia [1 ]
Lu, Wenqi [1 ]
Zheng, Xiaoyan [1 ]
机构
[1] First Hosp Qinhuangdao, Dept Nutr, Qinhuangdao, Hebei, Peoples R China
关键词
Depressive symptoms; NHANES; Females; 25-hydroxyvitamin D-2; VITAMIN-D DEFICIENCY; MAJOR DEPRESSION; EPIDEMIOLOGY; D-2; SUPPLEMENTATION; ERGOCALCIFEROL; WOMEN;
D O I
10.1016/j.jad.2021.09.102
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The role of vitamin D in depression has been gaining increased research interest. However, little is known about the independent associations of serum 25-hydroxyvitamin D3 (25(OH)D3) and D2 (25(OH)D2) with depressive symptoms. The goal of this study was to examine the metabolites of vitamin D and their associations with depression. Methods: This study was conducted in US females using data from the National Health and Nutrition Examination Survey 2011-2014. Depressive symptoms were assessed using a nine-item Patient Health Questionnaire, and serum 25(OH)D3 and 25(OH)D2 levels were measured using liquid chromatography-tandem mass spectrometry. Linear regression and generalized additive models were applied to evaluate the associations between 25(OH)D3, 25(OH)D2 and depression. Results: A negative association between serum 25(OH)D3 and depressive symptoms was observed in the fully adjusted model. This association was also found among widowed, divorced, separated, and never-married individuals. The association between 25(OH)D2 and depressive symptoms was not statistically significant, but the dose-response analysis revealed an inverted U-shaped relationship between them with an inflection point at 56.2 nmol/L. To the left of the inflection point, we detected a positive association between 25(OH)D2 and depressive symptoms, whereas a negative association was observed to the right of the inflection point. Limitations: The study used a cross-sectional approach, so causation cannot be determined. Conclusions: Our study shows an inverse linear association between serum 25(OH)D3 and depressive symptoms in US females. The association between 25(OH)D2 and depression follows an inverted U-shaped curve with the inflection point at 56.2 nmol/L.
引用
收藏
页码:342 / 349
页数:8
相关论文
共 50 条
  • [31] RAPID QUANTITATION OF SERUM 25-HYDROXYVITAMIN D3 AND D2 BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
    Healy, M.
    Cox, G.
    Casey, M.
    Walsh, J. Bernard
    Laird, E.
    Crowley, V.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S507 - S508
  • [32] Development of an ID-LC-MS-MS method for quantitation of serum 25-hydroxyvitamin D2 and D3
    Maunsell, Z
    Wright, DJ
    Rainbow, SJ
    CLINICA CHIMICA ACTA, 2005, 355 : S243 - S244
  • [33] Association of Serum 25-hydroxyvitamin D3 And D2 With Endothelial Function and Arterial Stiffness in Coronary Artery Disease
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Oikonomou, Evangelos
    Maniatis, Konstantinos
    Kioufis, Stamatios
    Kokkou, Eleni
    Zaromitidou, Marina
    Mazaris, Savvas
    Konsola, Theodosia
    Vavuranakis, Manolis
    Zisimos, Konstantinos
    Miliou, Antigoni
    Stamouli, Christina
    Stefanadis, Christodoulos
    CIRCULATION, 2013, 128 (22)
  • [34] A simple and sensitive LC-MS/MS method for measuring serum 25-hydroxyvitamin D2 and D3
    Chan, Y. M.
    Stiess, K.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A113 - A113
  • [35] Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis
    H. C. Hoeck
    B. Li
    P. Qvist
    Osteoporosis International, 2009, 20
  • [36] The impact 25-hydroxyvitamin D3 and D2 serum levels on vascular function in patients with coronary artery disease
    Siasos, G.
    Tousoulis, D.
    Oikonomou, E.
    Maniatis, K.
    Kioufis, S.
    Kokkou, E.
    Zaromitidou, M.
    Mazaris, S.
    Konsola, T.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1126 - 1126
  • [37] Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis
    Hoeck, H. C.
    Li, B.
    Qvist, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (08) : 1329 - 1335
  • [38] Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance
    Hsu, Simon
    Zelnick, Leila R.
    Lin, Yvonne S.
    Best, Cora M.
    Kestenbaum, Bryan R.
    Thummel, Kenneth E.
    Hoofnagle, Andrew N.
    de Boer, Ian H.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2022, 217
  • [39] Measurement of serum 3-epi-25-hydroxyvitamin D3, 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in infant, paediatric and adolescent populations of Korea using ultra-performance liquid chromatography-tandem mass spectrometry
    Cho, Sung E.
    Kim, Sollip
    Kim, Young D.
    Lee, Hyojung
    Seo, Dong H.
    Song, Junghan
    Um, Tae H.
    Cho, Chong R.
    Kim, Nam H.
    Hwang, Jong H.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2017, 54 (05) : 530 - 538
  • [40] Associations of Free Serum 25-hydroxyvitamin D and Vitamin D Binding Protein Isoforms with 25-hydroxyvitamin D Clearance
    Best, Cora
    Hsu, Simon
    Lin, Yvonne
    Thummel, Kenneth
    Zelnick, Leila
    Kestenbaum, Bryan
    Kushnir, Mark
    de Boer, Ian
    Hoofnagle, Andrew
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 207 - 207